44Indexed trials
Market Rank #48 · Evidence Tier A
South Africa
Neuroscience Intelligence
South Africa neuroscience intelligence: 44 indexed trials, 29 institutions, research score 26.91.
2Recruiting
29Research institutions
26.9Research score
Evidence profile
31Sponsors
14Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 26.9 · Data confidence 100.00 · Evidence 26.9
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons9trials
alzheimers7trials
depression5trials
pain_neuropathy4trials
autism4trials
stroke3trials
other_neurology2trials
epilepsy2trials
schizophrenia2trials
bipolar_disorder2trials
Leading indexed sponsors
Pfizer4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Merck Sharp & Dohme LLC4trials
Sumitomo Pharma America, Inc.3trials
Forest Laboratories2trials
Novo Nordisk A/S2trials
Bristol-Myers Squibb1trials
Boehringer Ingelheim1trials
BRC Operations Pty. Ltd.1trials
Daiichi Sankyo1trials